第1页参见附件。
doi：10.3969/j.issn.1007-614x.2014.11.18
摘 要 目的：探讨甘精胰岛素联合瑞格列奈治疗初诊2型糖尿病的临床疗效。方法：收治初诊T2DM患者40例，经甘精胰岛素联合瑞格列奈治疗16周，比较治疗前后空腹血糖(FBG)、餐后2小时血糖(PBG)、糖化血红蛋白(HbA1C)的差异，同时观察总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白(LDL-C)、血常规、肝、肾功能的变化及体重指数(BMI)，低血糖的药物不良反应。结果：治疗12周后，与治疗前相比，FBG、PBG、HbA1C均降低(P0.05)，有低血糖反应3例次。结论：甘精胰岛素联合瑞格列奈治疗初诊T2DM患者，能使血糖下降明显，且不良反应轻微、安全。
关键词 甘精胰岛素 瑞格列奈 2型糖尿病
Curative effect observation of insulin glargine combined with repaglinide in the treatment of newly diagnosed type 2 diabetes
Huang Ruihua
Department of Endocrinology，the People's Hospital of Pizhou City，Jiangsu 221300
Abstract Objective：To investigate the clinical efficacy of insulin glargine combined with repaglinide in the treatment of newly diagnosed type 2 diabetes.Methods：40 newly diagnosed patients with T2DM were selected ......
http://www.100md.com/html/paper/1007-614X/2014/11/18.htm
您现在查看是摘要介绍页，详见PDF附件。
